Lupin’s Pegfilgrastim Biosimilar Accepted By US FDA

Neulasta Rival Faces A Crowded Market With Four Approved Competitors

 
• By David Wallace
  
Motorbike Race Track Motorcycle
Lupin is planning to join a crowded field for biosimilar pegfilgrastim • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products